Pharmaceuticals · Key players

Top MASH (NASH) Therapeutics companies

The 6 key players our MASH (NASH) Therapeutics report profiles, and other companies free public records show in this market.

Key players in MASH (NASH) Therapeutics

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the MASH (NASH) Therapeutics market
#CompanyWebsiteOur reports
1 Madrigal Pharmaceuticals — 66 reports
2 Novo Nordisk A/S novo.com (opens in a new tab) 495 reports
3 Akero Therapeutics — 33 reports
4 89bio — 33 reports
5 Inventiva — 33 reports
6 Boston Pharmaceuticals — 33 reports

Also active in MASH (NASH) Therapeutics

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in MASH (NASH) Therapeutics, from free public records
CompanyWhere public records show them
Regeneron Pharmaceuticals
GSK PLC
Boehringer Ingelheim GmbH
Eccogene
Roche
Zhejiang Doer Biologics Co., Ltd.
Wuxi Hisky Medical Technology Co Ltd
Perspectum

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in MASH (NASH) Therapeutics

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Regeneron Pharmaceuticals 7 active trials on ClinicalTrials.gov (opens in a new tab)
  2. GSK PLC 4 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Boehringer Ingelheim GmbH 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Eccogene 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Madrigal Pharmaceuticals 3 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Akero Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Roche 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Zhejiang Doer Biologics Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

MASH (NASH) Therapeutics reports by place

All 33 places for MASH (NASH) Therapeutics

Get the full MASH (NASH) Therapeutics report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.